Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News REMSleep Holdings Inc RMSL

Healthcare Medical Devices
REMSleep Holdings, Inc. is a medical technology company. The Company is focused on the development and commercialization of solutions for patients with obstructive sleep apnea. Its DeltaWave CPAP interface (the DeltaWave), which is a device to treat patients with sleep apnea. The patent-pending DeltaWave product is a nasal-pillow type interface that is designed with airflow characteristics to... see more

Recent & Breaking News (OTCQB:RMSL)

REMSleep Patent Application Has Been Allowed by the United States Patent and Trademark Office

GlobeNewswire September 3, 2024

REMSleep Holdings Inc. Issues Shareholder Letter

GlobeNewswire August 6, 2024

REMSleep Holdings, Inc. Announces Distributor Request for DELTAWAVE Nasal Pillows System Samples

GlobeNewswire July 24, 2024

REMSleep Holdings Inc. Announces Strategic Marketing Plan for DELTAWAVE Nasal Pillows System

GlobeNewswire July 17, 2024

REMSleep Holdings Inc. Receives 510(K) Clearance on Product

GlobeNewswire July 9, 2024

REMSleep Holdings Patent Status

GlobeNewswire March 6, 2024

REMSleep Holdings Shareholder Update

GlobeNewswire March 4, 2024

Remsleep Holdings Inc.'s DeltaWave Mask has received questions from FDA regarding 510k submission (K233415)

GlobeNewswire January 22, 2024

Remsleep Holdings Inc.'s DeltaWave Mask Moves to Substantive Review of FDA 510k Process

Accesswire November 2, 2023

RemSleep Holdings Inc. Announces Submission of DeltaWave Mask for FDA 510K Review

Accesswire October 6, 2023

RemSleep Holdings Inc. Provides an Update on Funding and DeltaWave

Accesswire September 25, 2023

RemSleep Holdings Inc. Announces Completion of DeltaWave CPAP Mask

Accesswire September 1, 2023

RemSleep Holdings Inc. Issues Letter to Shareholders

GlobeNewswire January 6, 2023

RemSleep Holdings Provides a Corporate Update on Testing

GlobeNewswire November 8, 2022

RemSleep Holdings Inc. Commences Trading on OTCQB

GlobeNewswire July 27, 2022

RemSleep Holdings Inc. Engages New Senior Director for Regulatory Compliance and New Regulatory Testing Company

GlobeNewswire July 22, 2022

RemSleep Holdings Inc. Issues Correction to July 12th, 2022 Press Release

GlobeNewswire July 19, 2022

RemSleep Holdings Inc. Announces Acceptance and Approval of the Company's OTCQB Application

GlobeNewswire July 12, 2022

RemSleep Holdings Inc Addresses Shareholders

GlobeNewswire June 16, 2022

RemSleep Holdings Inc. Submits Application For Uplisting to OTCQB

GlobeNewswire June 10, 2022